Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 10.31% is 77% below its 4-year average of 43.89%, near the low end of its 4-year range (0.00%–100.00%).
5.24% above its 12-month average of 9.80%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 7.99%.
GROSS MARGIN
10.31%
GROSS MARGIN AVG TTM
9.80%
GROSS MARGIN AVG 3Y
38.01%
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+5.24%
CURRENT VS 3Y AVG
-72.87%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.44%
median of 787 covered companies
CURRENT VS SECTOR MEDIAN
-74.51%
vs the sector median at left
Market Cap
$1.50M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.45M
Gross Margin
33.34%
TTM Avg
40.48%
3Y Avg
28.36%
5Y Avg
50.23%
Market Cap
$1.38M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.65M
Gross Margin
-1128.89%
TTM Avg
-518.50%
3Y Avg
-213.30%
5Y Avg
-126.70%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | $1.48M | 10.31% | 9.80% | 38.01% | N/A |
| Curis, Inc. (CRIS)vs › | $1.47M | 99.28% | 99.31% | 98.49% | 97.34% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.50M | 0.00% | 0.00% | 0.00% | 0.00% |
| NEXGEL, Inc. (NXGL)vs › | $1.43M | 35.07% | 35.55% | 23.19% | 8.35% |
| INVO Fertility, Inc. (IVF)vs › | $1.45M | 33.34% | 40.48% | 28.36% | 50.23% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.38M | 0.00% | 0.00% | 0.00% | 0.00% |
| Genprex, Inc. (GNPX)vs › | $1.34M | 0.00% | 0.00% | 0.00% | 0.00% |
| NewcelX Ltd. (NCEL)vs › | $1.32M | 0.00% | 0.00% | 0.00% | 0.00% |
| Silo Pharma, Inc. (SILO)vs › | $1.65M | -1128.89% | -518.50% | -213.30% | -126.70% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.27M | 88.34% | 40.30% | 45.15% | 63.43% |
Gross Margin
10.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 7.99% |
| 2026-03-31 | 10.42% |
| 2025-12-31 | 15.63% |
| 2025-09-30 | 14.95% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 100.00% |
| 2024-09-30 | 74.68% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 72.52% |
| 2023-12-31 | 66.09% |
| 2023-09-30 | 66.01% |
| 2023-06-30 | 65.82% |
| 2023-03-31 | 68.89% |
| 2022-12-31 | 67.25% |
| 2022-09-30 | 55.01% |
| 2022-06-30 | 61.95% |
| 2022-03-31 | 42.75% |
